Showing 1–11 of 11 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Bidyarani Devi Konjengbam, Heikrujam Nilkanta Meitei, Anupama Pandey, Reena Haobam
… and its preclinical and clinical trials. Additionally, DNA vaccines and their vaccination techniques are also discussed. Furthermore, the immunoinformatics approach and nanomaterial-based vaccine delivery with practical and productive endpoints are also discussed. Lastly, the po…
Ahmed Al Hammadi, Fatima Ali Salem Khalfan Al Dhaheri, Huda Sulaiman Al Dhanhani, Jens Thomsen
…on had been vaccinated with at least one dose of a COVID-19 vaccines, resulting in a mortality rate of only 0.24%, making it one of the lowest in the world.
Kenneth W Foreman, Hui-Chen Foreman
Tuberculosis (TB), primarily caused by(Mtb), remains a leading cause of infectious disease mortality worldwide. Global TB control efforts face several hurdles, including the lack of a broadly effective vaccine, limited sensitivity of current diagnostics, particularly for paucibac…
Ted Lankester
Abstract This chapter describes the recent status, impact, and control of tuberculosis (TB) worldwide through the End TB strategy. It gives examples of how government and civil society programmes can work together, with the roles and tasks of each clearly defined. It gives exampl…
Anjali Saxena, Summer Bhagra, Shuvayoo Das, Naveen Kaushik, Biswajit Saha
TB remains a significant global health burden due to protracted therapeutic courses, poor patient compliance, and toxicities associated with drug treatment, as well as concerns arising from increasingly prevalent multidrug-resistant and extensively drug-resistant strains of M. tu…
Parissa Farnia, Ali Akbar Velayati, Jalaledin Ghanavi, Poopak Farnia
…ng years of progress. Despite the availability of effective vaccines and treatment regimens, gaps in awareness, funding, healthcare infrastructure, and social determinants of health hinder global elimination efforts. Coordinated, multisectoral strategies are essential to address …
Xinen Kong, Jiayi Yang, Jiajun Wang, Jiaxiang Li, Xiaoying Jin, et al.
…mmunodeficiency virus (HIV) co-infection, lack of effective vaccines and diagnosis methods, as well as the low treatment efficacy of anti-TB therapeutics lead to multiple difficulties and challenges in TB control. Host immune defense is critical for the processes and outcome of M…
Omid Nikjeh, Seyedehparmis Rejali, Kayvan Sasaninia, Vishwanath Venketaraman
…uding interferon-γ, GM-CSF, and IL-7; and therapeutic vaccines (M72/AS01E, MTBVAC, VPM1002) as promising adjuncts. Distinct from guideline-focused overviews, this review emphasizes non-tuberculous mycobacterial disease (NTM, including MAC) and leprosy in PLWH and synthesize…
Pulak Pritam, Sreelipta Das, Sandeep Kumar Behera, Monali Sahoo, Lopamudra Subudhi, et al.
The disease tuberculosis, caused by, is one of the leading causes of global human mortality. The rise of multidrug and extensively drug-resistant strains of the pathogen and the limited efficacy of the BCG vaccine is one of the major concerns worldwide. Conventional chemotherapy …
Vaishali N. Pardeshi, Tushar Lokhande, Khemchand R. Surana, Ashwini Shelke, Yogita B. Thombare
Tuberculosis (TB) is still a significant public health issue across the world, especially with the advent of multidrug-resistant TB. The incapacity of humans to manage this illness derives from the fact that formerly successful TB vaccinations and treatments are no longer effecti…
Apoorva Narain, Surya Kant, Rikesh K. Dubey, Kanchan Srivastava, Anand Kumar Maurya
… diseases. Also, it can aid in the development of effective vaccines as well as simple, rapid, and cost-effective tests for the diagnosis of TB, which are crucial for the management and control of the disease.